JY
DTIL icon

Jeff Yass’s Precision BioSciences DTIL Stock Holding History

Jeff Yass’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Sell
32,897
-31,565
-49% -$222K ﹤0.01% 11377
2026
Q1 		$355K Sell
64,462
-2,119
-3% -$9.78K ﹤0.01% 10497
2025
Q4 		$277K Buy
+66,581
New +$378K ﹤0.01% 10136
2025
Q1 		– Sell
-27,537
Closed -$105K – 12683
2024
Q4 		$105K Buy
+27,537
New +$201K ﹤0.01% 11305
2023
Q4 		– Sell
-3,396
Closed -$34.8K – 12532
2023
Q3 		$34.8K Buy
+3,396
New +$52.2K ﹤0.01% 11431
2023
Q2 		– Sell
-7,122
Closed -$161K – 12281
2023
Q1 		$161K Sell
7,122
-106
-1% -$3.49K ﹤0.01% 10847
2022
Q4 		$258K Buy
7,228
+5,977
+478% +$236K ﹤0.01% 9475
2022
Q3 		$49K Sell
1,251
-3,013
-71% -$143K ﹤0.01% 12213
2022
Q2 		$205K Buy
4,264
+1,709
+67% +$100K ﹤0.01% 10565
2022
Q1 		$236K Sell
2,555
-633
-20% -$86K ﹤0.01% 10837
2021
Q4 		$708K Buy
3,188
+942
+42% +$263K ﹤0.01% 8224
2021
Q3 		$777K Sell
2,246
-2,496
-53% -$846K ﹤0.01% 8211
2021
Q2 		$1.78M Buy
4,742
+1,587
+50% +$477K ﹤0.01% 6184
2021
Q1 		$979K Sell
3,155
-2,079
-40% -$728K ﹤0.01% 7800
2020
Q4 		$1.31M Buy
5,234
+1,181
+29% +$289K ﹤0.01% 6049
2020
Q3 		$749K Buy
4,053
+167
+4% +$33.2K ﹤0.01% 6812
2020
Q2 		$971K Buy
3,886
+2,782
+252% +$609K ﹤0.01% 5997
2020
Q1 		$200K Sell
1,104
-1,657
-60% -$434K ﹤0.01% 8694
2019
Q4 		$1.15M Buy
+2,761
New +$867K ﹤0.01% 5257

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Jeff Yass's DTIL Position: Q2 2026 in Review

Jeff Yass reduced its Precision BioSciences (DTIL) stake by 49% in Q2 2026, selling an estimated $222K and leaving 32,897 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #11377.

Jeff Yass first reported a position in DTIL in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.78M in Q2 2021. 94 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Jeff Yass held 32,897 shares of Precision BioSciences worth $259K as of Q2 2026.
  • Jeff Yass sold 31,565 Precision BioSciences shares in Q2 2026, an estimated $222K.
  • Precision BioSciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11377 holding.
  • Jeff Yass first reported a position in Precision BioSciences in Q4 2019 and has held it in 19 quarters since.
  • Jeff Yass's Precision BioSciences position peaked at $1.78M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.